822-39-9Relevant academic research and scientific papers
Five-membered ring phosphite compound, and preparation method and application thereof
-
Paragraph 0090; 0092-0093, (2020/06/17)
The invention belongs to the technical field of batteries, and especially relates to a five-membered ring phosphite compound. The structural general formula of the five-membered ring phosphite compound is represented by formula 1 shown in the description; and in the formula, R, R, R, R, R, R, R, R, R, R, R, R, R, R, R, R, R and R are independently selected from hydrogen, an alkyl group, an alkenyl group, an alkynyl group, an alkoxy group, an alkynyloxy group, an enyloxy group, a silyl group, a siloxane group, aryl silicon, an arylsilyl group, an arylsiloxy group, a halogenated alkyl group, a phenyl group, a biphenyl group, a naphthyl group, a pyridyl group, a thienyl group, a halogenated phenyl group, a halogenated biphenyl group, a phenolic group, an alkyl-containing phenolic group, an alkenyl-containing phenolic group, an alkynyl-containing phenolic group, a nitrile-containing phenolic group, a monohalogenated phenolic group and a polyhalogenated phenolic group. The five-membered ring phosphite compound provided by the invention has excellent flame retardant property, can effectively prevent electrolytes from being oxidized when being applied to the field of batteries, reduces oxygenolysis of the electrolytes on positive electrodes, and remarkably improves the comprehensive properties such as high temperature, circulation, storage and the like of the batteries.
Phosphine ligand compound and preparation method thereof, catalyst composition and application thereof and vinyl acetate hydroformylation method (by machine translation)
-
Paragraph 0077-0080, (2020/07/13)
The invention relates to the field of vinyl acetate hydroformylation, and discloses a phosphine ligand compound and a preparation method thereof, a catalyst composition and application of the phosphine ligand compound and vinyl acetate hydroformylation. The phosphine ligand compound has the structure shown in the formula (1); and A and B1 And B2 C is each independently selected from substituted or unsubstituted C1 - C20 Alkylene; and A, B1 And B2 The optionally present substituents are each independently selected from C. 1 - C20 Alkyl, halogen and C1 - C10 The phosphorus ligand compound provided by the invention can effectively improve the vinyl acetate conversion rate and 2 - acetoxy propionaldehyde selectivity. (by machine translation)
Phosphine ligand compound and preparation method thereof, catalyst composition and application thereof, and vinyl acetate hydroformylation method
-
Paragraph 0091-0094, (2020/07/13)
The invention relates to the field of vinyl acetate hydroformylation, and discloses a phosphine ligand compound and a preparation method thereof, a catalyst composition and application thereof, and avinyl acetate hydroformylation method. The phosphine ligand compound has a structure shown as a formula (1); wherein A is selected from substituted or unsubstituted biphenyl; B1 and B2 are each independently selected from substituted or unsubstituted C1-C20 alkylene groups; substituent groups optionally existing in A, B1 and B2 are respectively and independently selected from at least one of C1-C20 alkyl, halogen, C1-C10 alkoxyl, hydroxyl, carboxyl and aldehyde group; and the provided phosphine ligand compound can effectively improve the conversion rate of vinyl acetate and the selectivity of2-acetoxy propionaldehyde.
Phosphine ligand compound and preparation method thereof, catalyst composition and application thereof and vinyl acetate hydroformylation method (by machine translation)
-
Paragraph 0079-0082, (2020/07/13)
The invention relates to the field of vinyl acetate hydroformylation, and discloses a phosphine ligand compound and a preparation method thereof, a catalyst composition and application of the phosphine ligand compound and vinyl acetate hydroformylation. The phosphine ligand compound has the structure shown in the formula (1); wherein A is selected from substituted or unsubstituted phenyl; B1 And B2 C is each independently selected from substituted or unsubstituted C1 - C20 Alkylene; A, B1 And B2 The optionally present substituents are each independently selected from C. 1 - C20 Alkyl, halogen and C1 - C10 The phosphorus ligand compound provided by the invention can effectively improve the vinyl acetate conversion rate and 2 - acetoxy propionaldehyde selectivity. (by machine translation)
Method of Preparing 1,1,6,6-tetrachloro-2,5-dioxa-1,6-diphoshexane
-
Page/Page column 9-13, (2019/09/05)
A method for manufacturing 1,1,6,6-tetrachloro-2,5-dioxa-1,6-diphoshexane according to the present invention is the method for manufacturing 1,1,6,6-tetrachloro-2,5-dioxa-1,6-diphoshexane represented by chemical formula 2 by phosphorylation of an ethylene glycol compound represented by chemical formula 1 in the presence of an organic base. The method has effects of having an easy manufacturing process, being able to mass produce, obtaining 1,1,6,6-tetrachloro-2,5-dioxa-1,6-diphoshexane in a high yield, and manufacturing 1,1,6,6-tetrachloro-2,5-dioxa-1,6-diphoshexane with the high yield and a high purity.COPYRIGHT KIPO 2019
Synthesis and ring-opening polymerization of glycidyl ethylene phosphate with a formation of linear and branched polyphosphates
Nifant'ev, Ilya E.,Shlyakhtin, Andrey V.,Bagrov, Vladimir V.,Komarov, Pavel D.,Kosarev, Maxim A.,Tavtorkin, Alexander N.,Minyaev, Mikhail E.,Roznyatovsky, Vitaly A.,Ivchenko, Pavel V.
, p. 155 - 157 (2018/04/05)
Newly obtained cyclic monomer, glycidyl ethylene phosphate, readily forms branched or linear polymers via ring-opening polymerization catalyzed by 1,5,7-triazabicyclo[4.4.0]dec-5-ene or by [(BHT)Mg(OBn)(THF)]2, respectively. The polymers obtained are promising for biomedical applications.
Preparation and application of reducing sensitive nano-micelle
-
Paragraph 0032; 0064; 0066, (2017/07/19)
The invention relates to preparation and application of a reducing sensitive nano-micelle, belonging to preparation and application of an amphiphilic block polymer. A hydrophilic section and a hydrophobic section of the amphiphilic block polymer are connected with each other by a reducing responsive sulfur-sulfur bond; the nano-micelle is formed by self-assembling; the reducing sensitive nano-micelle consists of a shell and an inner core, wherein the shell is a hydrophilic polymer, and the inner core is a hydrophobic polymer; the hydrophilic section of the amphiphilic block polymer is polyphosphate, the hydrophobic section of the amphiphilic block polymer is poly(benzyl glutamate), and the hydrophilic section and the hydrophobic section of the amphiphilic block polymer are connected with each other by the reducing responsive sulfur-sulfur bond. The reducing sensitive nano-micelle has the advantages that the drug-loaded nano-micelle is difficult to dissociate outside the cells or in the blood, so that the drug encapsulated in the nano-micelle is enabled to be stable; once the nano-micelle enters the cancer cell, the sulfur-sulfur bond can be disconnected by glutathione which is a reducing matter in the cell, so that the nano-micelle is rapidly dissociated, the anti-cancer drug encapsulated in the nano-micelle can be rapidly and effectively released out, and an effective treatment effect is achieved; the reducing sensitive nano-micelle overcomes the defects that the drug is easy to leak in vivo, low in transport efficiency, slow in intracellular release speed, and the like.
Breathing air as oxidant: Optimization of 2-chloro-2-oxo-1,3,2-dioxaphospholane synthesis as a precursor for phosphoryl choline derivatives and cyclic phosphate monomers
Becker, Greta,Wurm, Frederik R.
, p. 3536 - 3540 (2017/06/01)
Phosphoryl choline derivatives are important compounds for drug development. Also other phosphoesters have received increased demand in recent years. Many of such compounds rely 2-chloro-2-oxo-1,3,2-dioxaphospholane (COP) as an intermediate. COP is available in a two-step reaction from the cyclic adduct of phosphorus chloride and ethylene glycol after oxidation. Although commercially available, in-house synthesis of COP is often required due to pricing, purity, and delivery issues. Air is a convenient and economical oxidizing agent, yet not used for synthesis of COP. While slow consumption of the P(III)-precursor 2-chloro-1,3,2-dioxaphospholane with molecular oxygen from a gas bottle, high amounts of unreacted oxygen are lavished and even may cause an explosion. Oxygen from air is a reasonable and safer alternative. Additionally, catalytic amounts of cobalt(II)chloride increase the reaction kinetics remarkably. The results presented allow a controlled and fast access to a variety of phosphoesters by optimized reaction conditions of COP and its derivatives.
Phosphoric acid phaseomannite class compound and its preparation method and application (by machine translation)
-
Paragraph 0198; 0199, (2017/07/14)
The invention discloses a phaseomannite class phosphate compound, phosphoric acid phaseomannite class compound preparation method, and these phosphoric acid phaseomannite class compounds in the preparation of an anti-tumor drug. The use of non-small cell lung cancer cells to the compounds of this invention to inhibit the growth of tumor cells in active testing, that the compounds of this invention have high inhibition of tumor cell growth activity, some of the compound inhibiting activity even with cisplatin active quite, which indicates that the compounds of this invention have good cell penetrability and phosphorus esterase stability, can be used for the development of anti-tumor medicament. (by machine translation)
BLOCK COPOLYMER, LIQUID COMPOSITE THEREOF, NUCLEIC ACID PREPARATION, PREPARATION METHODS THEREFOR, AND USE THEREOF
-
Paragraph 0093, (2015/04/15)
Provided are a polycaprolactone-polyphosphate block copolymer, a liquid composite formed by the block copolymer, a nucleic acid preparation, preparation methods for the copolymer and the liquid composite, and the use of the copolymer and the liquid composite in a nucleic acid medicine delivery system. The block copolymer prepared using the present invention has good biocompatibility, low cytotoxicity, and good biodegradability. The micelles provided in the present invention self-assemble into nano-particles in an aqueous solution, and have good stability, biocompatibility, and biodegradability, and low cytotoxicity. The preparation method is simple, has high repeatability, as a vector can protect small nucleic acids such as siRNA from biodegradation, can combine with the scale effect of nano-particles, and can be used for treating different diseases. Additionally, bonding targeting groups enable specificity recognition of different cancer cells.
